학술논문

Clinical and molecular heterogeneity in patients with innate resistance to anti-pd-1 +/− anti-ctla-4 immunotherapy in metastatic melanoma reveals distinct therapeutic targets
Document Type
Article
Source
In: Cancers. (Cancers, 1 July 2021, 13(13))
Subject
Language
English
ISSN
20726694